159 related articles for article (PubMed ID: 25253431)
1. RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer.
Koh SA; Kim MK; Lee KH; Kim SW; Kim JR
Clin Exp Metastasis; 2014 Oct; 31(7):805-15. PubMed ID: 25253431
[TBL] [Abstract][Full Text] [Related]
2. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J
Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor induced up-regulations of VEGF through Egr-1 in hepatocellular carcinoma cells.
Lee KH; Kim JR
Clin Exp Metastasis; 2009; 26(7):685-92. PubMed ID: 19526316
[TBL] [Abstract][Full Text] [Related]
4. BAG3 contributes to HGF-mediated cell proliferation, migration, and invasion via the Egr1 pathway in gastric cancer.
Lee JC; Koh SA; Lee KH; Kim JR
Tumori; 2019 Feb; 105(1):63-75. PubMed ID: 30514177
[TBL] [Abstract][Full Text] [Related]
5. Cold-shock Domain Protein A (CSDA) Influences Hepatocyte Growth Factor-medicated Cell Proliferation and Metastasis in Gastric Cancer Cells.
Jung JY; Koh SA; Lee KH
Anticancer Res; 2024 May; 44(5):1973-1981. PubMed ID: 38677740
[TBL] [Abstract][Full Text] [Related]
6. RNA interference-mediated knockdown of RhoGDI2 induces the migration and invasion of human lung cancer A549 cells via activating the PI3K/Akt pathway.
Niu H; Wu B; Peng Y; Jiang H; Zhang Y; Wang J; Zhang Y; He P
Tumour Biol; 2015 Jan; 36(1):409-19. PubMed ID: 25266803
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB.
Lee KH; Choi EY; Koh SA; Kim MK; Kim KO; Lee SH; Jang BI; Kim SW; Kim SW; Song SK; Choi JH; Kim JR
Exp Mol Med; 2011 Sep; 43(9):501-9. PubMed ID: 21734448
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor-mediated gastrin-releasing peptide induces IL-8 expression through Ets-1 in gastric cancer cells.
Lee KH; Koh SA; Kim JR
Oncol Res; 2013; 20(9):393-402. PubMed ID: 23924923
[TBL] [Abstract][Full Text] [Related]
9. 14-3-3σ attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells.
Kim IK; Park SM; Cho HJ; Baek KE; Nam IK; Park SH; Ryu KJ; Ryu J; Choi J; Hong SC; Kim JW; Lee CW; Kang SS; Yoo J
Oncotarget; 2013 Nov; 4(11):2045-56. PubMed ID: 24185104
[TBL] [Abstract][Full Text] [Related]
10. RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells.
Cho HJ; Park SM; Kim IK; Nam IK; Baek KE; Im MJ; Yoo JM; Park SH; Ryu KJ; Han HT; Kim HJ; Hong SC; Kim KD; Pak Y; Kim JW; Lee CW; Yoo J
Oncotarget; 2014 Mar; 5(6):1554-64. PubMed ID: 24721928
[TBL] [Abstract][Full Text] [Related]
11. Rho GDP dissociation inhibitor beta promotes cell proliferation and invasion by modulating the AKT pathway in hepatocellular carcinoma.
Fang Y; Yi J; Lizhi L; Qiucheng C
DNA Cell Biol; 2014 Nov; 33(11):781-6. PubMed ID: 25180836
[TBL] [Abstract][Full Text] [Related]
12. Adenosine Inhibits Ovarian Cancer Growth Through Regulating RhoGDI2 Protein Expression.
Xia B; Wang J
Drug Des Devel Ther; 2019; 13():3837-3844. PubMed ID: 32109988
[TBL] [Abstract][Full Text] [Related]
13. IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment.
Lee KH; Choi EY; Koh SA; Kim MK; Jang BI; Kim SW; Kim JR
Oncol Rep; 2014 May; 31(5):2123-30. PubMed ID: 24626561
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3 Sigma Protein Contributes to Hepatocyte Growth Factor-mediated Cell Proliferation and Invasion
Jung JY; Koh SA; Lee KH; Kim JR
Anticancer Res; 2022 Jan; 42(1):519-530. PubMed ID: 34969762
[TBL] [Abstract][Full Text] [Related]
15. Hepatoma-derived growth factor regulates the bad-mediated apoptotic pathway and induction of vascular endothelial growth factor in stomach cancer cells.
Lee KH; Choi EY; Kim MK; Lee SH; Jang BI; Kim TN; Kim SW; Kim SW; Song SK; Kim JR; Jung BC
Oncol Res; 2010; 19(2):67-76. PubMed ID: 21302807
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of RhoGDI2 represses human gastric cancer cell proliferation, invasion and drug resistance via the Rac1/Pak1/LIMK1 pathway.
Zeng Y; Ren M; Li Y; Liu Y; Chen C; Su J; Su B; Xia H; Liu F; Jiang H; Ling H; Zeng X; Su Q
Cancer Lett; 2020 Nov; 492():136-146. PubMed ID: 32860848
[TBL] [Abstract][Full Text] [Related]
17. Depletion of RhoGDI2 expression inhibits the ability of invasion and migration in pancreatic carcinoma.
Yi B; Hu Y; Qin G; Gu W; Zhu X; He S; Zhou J; Li D
Int J Mol Med; 2014 Jul; 34(1):205-12. PubMed ID: 24788627
[TBL] [Abstract][Full Text] [Related]
18. Kiss-1 suppresses MMP-9 expression by activating p38 MAP kinase in human stomach cancer.
Lee KH; Kim JR
Oncol Res; 2009; 18(2-3):107-16. PubMed ID: 20066900
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
